Company Information
USD
171.03
- (-2.8%)
NASDAQ:RGEN, REPLIGEN CORPORATION
Industry: Medical Instruments & Supplies
End of Day: 16 May 2024 GMT-4
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Address
41 Seyon Street
Building 1, Suite 100
Website
Classification
Sector
Healthcare
Industry Group
Medical Devices & Instruments
Industry
Medical Instruments & Supplies
Key Executives
Mr. Glenn P. Muir
Director
Ms. Karen A. Dawes, M.A.,M.B.A.
Chairman of the Board/Director
Mr. Nicolas M. Barthelemy
Director
Dr. Martin D. Madaus,PhD
Director
Mr. Tony J. Hunt
CEO/Director
Ms. Carrie Eglinton Manner
Director
Mr. Jason K. Garland
CFO
Dr. Rohin Mhatre
Director
Dr. Konstantin Konstantinov
Director
Mr. Olivier Loeillot
Other Executive Officer/President
Mr. Ralf Kuriyel
Senior VP, Divisional
Ms. Christine Gebski
Senior VP, Divisional
Mr. James Bylund
COO
Ownership
Institution Holdings
BlackRock Inc
7,859,645 (14.093%)
Vanguard Group Inc
5,078,294 (9.106%)
T. Rowe Price Associates, Inc.
4,010,255 (7.191%)
BlackRock Fund Advisors
3,170,805 (5.685%)
FMR Inc
1,882,516 (3.375%)
Fidelity Management & Research Company LLC
1,872,180 (3.357%)
State Street Corporation
1,703,618 (3.055%)
Vanguard Investments Australia Ltd
1,687,867 (3.026%)
Macquarie Group Ltd
1,568,792 (2.813%)
Macquarie Investment Management Aus Ltd.
1,568,792 (2.813%)
Individual Holdings
Mr. Tony J. Hunt
213,208 (0.382%)
Ms. Karen A. Dawes, M.A.,M.B.A.
87,367 (0.157%)
Ms. Christine Gebski
28,270 (0.051%)
Mr. Ralf Kuriyel
27,027 (0.049%)
Mr. Olivier Loeillot
15,786 (0.028%)
Mr. Jason K. Garland
8,043 (0.014%)
Mr. Glenn P. Muir
7,582 (0.014%)
Mr. Nicolas M. Barthelemy
2,767 (0.005%)
Ms. Carrie Eglinton Manner
2,792 (0.005%)
Dr. Rohin Mhatre
2,345 (0.004%)
Funds Holdings
T. Rowe Price New Horizons Fund
2,461,373 (4.413%)
US Small-Cap Growth II Equity Comp
2,461,373 (4.413%)
Vanguard US Total Market Shares ETF
1,661,276 (2.979%)
Vanguard Total Stock Market Index Fund
1,661,276 (2.979%)
iShares Core S&P Mid-Cap ETF
1,580,673 (2.834%)
Sands Capital Global Growth Equity
1,367,177 (2.451%)
Vanguard Small Cap Index
1,354,464 (2.429%)
BlackRock Mid-Cap Growth Equity Port
1,188,384 (2.131%)
Champlain Mid Cap Fund, LLC
909,015 (1.630%)
Vanguard Institutional Extnd Mkt Idx Tr
766,334 (1.374%)
Make Smart Investment Choices